EWJ:US
$325.00
3.791%

Alnylam Pharmaceuticals Inc.
Key Data

Last updated: Jun 24, 2025, 9:38 PM ET

Price Metrics  

  • Open
    316.51
  • Close
    325.00
  • Prev. Close
    313.13
  • Day High/Low
    326.03/309.96
  • 52 Week High/Low
    326.03/205.87
  • Alpha
    0.019
  • Beta
    0.215
  • VWAP
    321.597

Moving Averages  

  • 21 Day Moving Average
    303.925
  • 50 Day Moving Average
    278.389
  • 200 Day Moving Average
    264.615

Valuation Metrics  

  • Market Cap (All Classes)
    42,376,227,725.00
  • Market Cap
    42,376,227,725.00
  • EPS (TTM)
    —
  • P/E Ratio (TTM)
    —
  • P/B Ratio
    353.69
  • P/CF Ratio
    -86.30
  • D/E Ratio
    11.28
  • Return on Equity
    —
  • Return on Assets
    -6.71%

Share Statistics  

  • Total Shares (All Classes)
    130,388,393.00
  • Listed Shares Outstanding
    130,388,393.00
  • Escrow Shares
    —
  • Volume
    1,000,030.00
  • 10 Day Avg Vol.
    731,883.00
  • 20 Day Avg Vol.
    901,575.00
  • 30 Day Avg Vol.
    900,343.00
  • 50 Day Avg Vol.
    933,513.00

Dividends  

  • Dividend
    —
  • Dividend Frequency
    —
  • Dividend Yield (Ann)
    —
  • Ex-Date
    —
  • Payable date
    —
  • Dividend Growth (3 Year)
    —
  • Dividend Growth (5 Year)
    —

Short Interest (as of Jun 25, 2025)  

  • Short Interest as % of Float
    -%
  • Short Interest Days to Cover
    -
Want more in-depth company research in real-time?
Learn more about TMX Powerstream today.